Ratings Auga Group AB London S.E.

Equities

Market Closed - London S.E. Other stock markets 12:03:30 2018-05-18 pm EDT			5-day change	1st Jan Change
0.5 ^EUR	-0.99%		-.--%	-.--%

Mar. 12	Auga Group AB Starts Production and Sale of Biomethane as New Commercial Activity	CI
Mar. 06	Transcript : Auga Group AB, 2023 Earnings Call, Mar 06, 2024

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
One of the major weak points of the company is its financial situation.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
AUGA GROUP AB	-.--%	71.74M		-
QL RESOURCES	+12.78%	3.29B		B
ROS AGRO PLC	-95.58%	1.61B	-	C+
SLC AGRÍCOLA S.A.	-0.48%	1.61B		C
GODREJ AGROVET LIMITED	-2.37%	1.25B		D+
FRESH DEL MONTE PRODUCE INC.	-2.40%	1.22B		B
SILDARVINNSLAN HF.	-11.54%	1.21B	-	-
CHERKIZOVO GROUP	-.--%	1.22B	-	-
SHENZHEN KINGKEY SMART AGRICULTURE TIMES CO.,LTD	-10.44%	1.2B		-
PT FAP AGRI TBK	0.00%	1.19B	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality